-
1
-
-
0035877299
-
Electron microscopic immunocytochemical detection of PSD-95, PSD-93, SAP-102, and SAP-97 at postsynaptic, presynaptic, and nonsynaptic sites of adult and neonatal rat visual cortex
-
Aoki C., Miko I., Oviedo H., Mikeladze-Dvali T., Alexandre L., Sweeney N., Bredt D.S. Electron microscopic immunocytochemical detection of PSD-95, PSD-93, SAP-102, and SAP-97 at postsynaptic, presynaptic, and nonsynaptic sites of adult and neonatal rat visual cortex. Synapse 2001, 40:239-257.
-
(2001)
Synapse
, vol.40
, pp. 239-257
-
-
Aoki, C.1
Miko, I.2
Oviedo, H.3
Mikeladze-Dvali, T.4
Alexandre, L.5
Sweeney, N.6
Bredt, D.S.7
-
2
-
-
79960057257
-
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
-
Autry A.E., Adachi M., Nosyreva E., Na E.S., Los M.F., Cheng P.F., Kavalali E.T., Monteggia L.M. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 2011, 475:91-95.
-
(2011)
Nature
, vol.475
, pp. 91-95
-
-
Autry, A.E.1
Adachi, M.2
Nosyreva, E.3
Na, E.S.4
Los, M.F.5
Cheng, P.F.6
Kavalali, E.T.7
Monteggia, L.M.8
-
3
-
-
84924814547
-
Potential use of lurasidone for the treatment of bipolar psychosis
-
Carta M.G., Moro M.F., Nardi A.E., Calabrese J.R. Potential use of lurasidone for the treatment of bipolar psychosis. Expert Opin. Investig. Drugs 2015, 24:575-584.
-
(2015)
Expert Opin. Investig. Drugs
, vol.24
, pp. 575-584
-
-
Carta, M.G.1
Moro, M.F.2
Nardi, A.E.3
Calabrese, J.R.4
-
4
-
-
84877004426
-
Effects of lurasidone in behavioral models of depression. Role of the 5-HT(7) receptor subtype
-
Cates L.N., Roberts A.J., Huitron-Resendiz S., Hedlund P.B. Effects of lurasidone in behavioral models of depression. Role of the 5-HT(7) receptor subtype. Neuropharmacology 2013, 70:211-217.
-
(2013)
Neuropharmacology
, vol.70
, pp. 211-217
-
-
Cates, L.N.1
Roberts, A.J.2
Huitron-Resendiz, S.3
Hedlund, P.B.4
-
5
-
-
84859268864
-
Long-term safety and tolerability of lurasidone in schizophrenia: a 12-month, double-blind, active-controlled study
-
Citrome L., Cucchiaro J., Sarma K., Phillips D., Silva R., Tsuchiya S., Loebel A. Long-term safety and tolerability of lurasidone in schizophrenia: a 12-month, double-blind, active-controlled study. Int Clin Psychopharmacol 2012, 27:165-176.
-
(2012)
Int Clin Psychopharmacol
, vol.27
, pp. 165-176
-
-
Citrome, L.1
Cucchiaro, J.2
Sarma, K.3
Phillips, D.4
Silva, R.5
Tsuchiya, S.6
Loebel, A.7
-
6
-
-
2942662069
-
Effects of chronic fluoxetine in animal models of anxiety and depression
-
Dulawa S.C., Holick K.A., Gundersen B., Hen R. Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 2004, 29:1321-1330.
-
(2004)
Neuropsychopharmacology
, vol.29
, pp. 1321-1330
-
-
Dulawa, S.C.1
Holick, K.A.2
Gundersen, B.3
Hen, R.4
-
7
-
-
84867227874
-
Synaptic dysfunction in depression: potential therapeutic targets
-
Duman R.S., Aghajanian G.K. Synaptic dysfunction in depression: potential therapeutic targets. Science 2012, 338:68-72.
-
(2012)
Science
, vol.338
, pp. 68-72
-
-
Duman, R.S.1
Aghajanian, G.K.2
-
8
-
-
84884670670
-
Bidirectional regulation of emotional memory by 5-HT1B receptors involves hippocampal p11
-
Eriksson T.M., Alvarsson A., Stan T.L., Zhang X., Hascup K.N., Hascup E.R., Kehr J., Gerhardt G.A., Warner-Schmidt J., Arango-Lievano M., Kaplitt M.G., Ogren S.O., Greengard P., Svenningsson P. Bidirectional regulation of emotional memory by 5-HT1B receptors involves hippocampal p11. Mol. Psychiatry 2013, 18:1096-1105.
-
(2013)
Mol. Psychiatry
, vol.18
, pp. 1096-1105
-
-
Eriksson, T.M.1
Alvarsson, A.2
Stan, T.L.3
Zhang, X.4
Hascup, K.N.5
Hascup, E.R.6
Kehr, J.7
Gerhardt, G.A.8
Warner-Schmidt, J.9
Arango-Lievano, M.10
Kaplitt, M.G.11
Ogren, S.O.12
Greengard, P.13
Svenningsson, P.14
-
9
-
-
79952820114
-
Predictive validity of a non-induced mouse model of compulsive-like behavior
-
Greene-Schloesser D.M., Van der Zee E.A., Sheppard D.K., Castillo M.R., Gregg K.A., Burrow T., Foltz H., Slater M., Bult-Ito A. Predictive validity of a non-induced mouse model of compulsive-like behavior. Behav. Brain Res. 2011, 221:55-62.
-
(2011)
Behav. Brain Res.
, vol.221
, pp. 55-62
-
-
Greene-Schloesser, D.M.1
Van der Zee, E.A.2
Sheppard, D.K.3
Castillo, M.R.4
Gregg, K.A.5
Burrow, T.6
Foltz, H.7
Slater, M.8
Bult-Ito, A.9
-
10
-
-
84883680045
-
Animal models of the serotonin syndrome: a systematic review
-
Haberzettl R., Bert B., Fink H., Fox M.A. Animal models of the serotonin syndrome: a systematic review. Behav. Brain Res. 2013, 256:328-345.
-
(2013)
Behav. Brain Res.
, vol.256
, pp. 328-345
-
-
Haberzettl, R.1
Bert, B.2
Fink, H.3
Fox, M.A.4
-
11
-
-
77953753014
-
Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity
-
Ishibashi T., Horisawa T., Tokuda K., Ishiyama T., Ogasa M., Tagashira R., Matsumoto K., Nishikawa H., Ueda Y., Toma S., Oki H., Tanno N., Saji I., Ito A., Ohno Y., Nakamura M. Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity. J. Pharmacol. Exp. Ther. 2010, 334:171-181.
-
(2010)
J. Pharmacol. Exp. Ther.
, vol.334
, pp. 171-181
-
-
Ishibashi, T.1
Horisawa, T.2
Tokuda, K.3
Ishiyama, T.4
Ogasa, M.5
Tagashira, R.6
Matsumoto, K.7
Nishikawa, H.8
Ueda, Y.9
Toma, S.10
Oki, H.11
Tanno, N.12
Saji, I.13
Ito, A.14
Ohno, Y.15
Nakamura, M.16
-
12
-
-
34548775973
-
Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test
-
Ishiyama T., Tokuda K., Ishibashi T., Ito A., Toma S., Ohno Y. Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test. Eur. J. Pharmacol. 2007, 572:160-170.
-
(2007)
Eur. J. Pharmacol.
, vol.572
, pp. 160-170
-
-
Ishiyama, T.1
Tokuda, K.2
Ishibashi, T.3
Ito, A.4
Toma, S.5
Ohno, Y.6
-
13
-
-
84873423314
-
Transcription factor Nurr1 maintains fiber integrity and nuclear-encoded mitochondrial gene expression in dopamine neurons
-
Kadkhodaei B., Alvarsson A., Schintu N., Ramskold D., Volakakis N., Joodmardi E., Yoshitake T., Kehr J., Decressac M., Bjorklund A., Sandberg R., Svenningsson P., Perlmann T. Transcription factor Nurr1 maintains fiber integrity and nuclear-encoded mitochondrial gene expression in dopamine neurons. Proc. Natl. Acad. Sci. USA 2013, 110:2360-2365.
-
(2013)
Proc. Natl. Acad. Sci. USA
, vol.110
, pp. 2360-2365
-
-
Kadkhodaei, B.1
Alvarsson, A.2
Schintu, N.3
Ramskold, D.4
Volakakis, N.5
Joodmardi, E.6
Yoshitake, T.7
Kehr, J.8
Decressac, M.9
Bjorklund, A.10
Sandberg, R.11
Svenningsson, P.12
Perlmann, T.13
-
14
-
-
84926305080
-
NMDA receptor subunits and associated signaling molecules mediating antidepressant-related effects of NMDA-GluN2B antagonism
-
Kiselycznyk C., Jury N.J., Halladay L.R., Nakazawa K., Mishina M., Sprengel R., Grant S.G., Svenningsson P., Holmes A. NMDA receptor subunits and associated signaling molecules mediating antidepressant-related effects of NMDA-GluN2B antagonism. Behav. Brain Res. 2015, 287:89-95.
-
(2015)
Behav. Brain Res.
, vol.287
, pp. 89-95
-
-
Kiselycznyk, C.1
Jury, N.J.2
Halladay, L.R.3
Nakazawa, K.4
Mishina, M.5
Sprengel, R.6
Grant, S.G.7
Svenningsson, P.8
Holmes, A.9
-
15
-
-
80052440262
-
Genetic, pharmacological and lesion analyses reveal a selective role for corticohippocampal GLUN2B in a novel repeated swim stress paradigm
-
Kiselycznyk C., Svenningsson P., Delpire E., Holmes A. Genetic, pharmacological and lesion analyses reveal a selective role for corticohippocampal GLUN2B in a novel repeated swim stress paradigm. Neuroscience 2011, 193:259-268.
-
(2011)
Neuroscience
, vol.193
, pp. 259-268
-
-
Kiselycznyk, C.1
Svenningsson, P.2
Delpire, E.3
Holmes, A.4
-
16
-
-
77955909841
-
MTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists
-
Li N., Lee B., Liu R.J., Banasr M., Dwyer J.M., Iwata M., Li X.Y., Aghajanian G., Duman R.S. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010, 329:959-964.
-
(2010)
Science
, vol.329
, pp. 959-964
-
-
Li, N.1
Lee, B.2
Liu, R.J.3
Banasr, M.4
Dwyer, J.M.5
Iwata, M.6
Li, X.Y.7
Aghajanian, G.8
Duman, R.S.9
-
17
-
-
84893636659
-
Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study
-
Loebel A., Cucchiaro J., Silva R., Kroger H., Hsu J., Sarma K., Sachs G. Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study. Am. J. Psychiatry 2014, 171:160-168.
-
(2014)
Am. J. Psychiatry
, vol.171
, pp. 160-168
-
-
Loebel, A.1
Cucchiaro, J.2
Silva, R.3
Kroger, H.4
Hsu, J.5
Sarma, K.6
Sachs, G.7
-
18
-
-
84893669193
-
Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study
-
Loebel A., Cucchiaro J., Silva R., Kroger H., Sarma K., Xu J., Calabrese J.R. Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study. Am. J. Psychiatry 2014, 171:169-177.
-
(2014)
Am. J. Psychiatry
, vol.171
, pp. 169-177
-
-
Loebel, A.1
Cucchiaro, J.2
Silva, R.3
Kroger, H.4
Sarma, K.5
Xu, J.6
Calabrese, J.R.7
-
19
-
-
84878832154
-
Behavioural and neuroplastic properties of chronic lurasidone treatment in serotonin transporter knockout rats
-
Luoni A., Hulsken S., Cazzaniga G., Racagni G., Homberg J.R., Riva M.A. Behavioural and neuroplastic properties of chronic lurasidone treatment in serotonin transporter knockout rats. Int. J. Neuropsychopharmacol./Off. Sci. J. Coll. Int. Neuropsychopharmacol. 2013, 16:1319-1330.
-
(2013)
Int. J. Neuropsychopharmacol./Off. Sci. J. Coll. Int. Neuropsychopharmacol.
, vol.16
, pp. 1319-1330
-
-
Luoni, A.1
Hulsken, S.2
Cazzaniga, G.3
Racagni, G.4
Homberg, J.R.5
Riva, M.A.6
-
20
-
-
84891605532
-
Anatomical specificity in the modulation of activity-regulated genes after acute or chronic lurasidone treatment
-
Luoni A., Rocha F.F., Riva M.A. Anatomical specificity in the modulation of activity-regulated genes after acute or chronic lurasidone treatment. Prog. Neuro-psychopharmacol. Biol. Psychiatry 2014, 50:94-101.
-
(2014)
Prog. Neuro-psychopharmacol. Biol. Psychiatry
, vol.50
, pp. 94-101
-
-
Luoni, A.1
Rocha, F.F.2
Riva, M.A.3
-
21
-
-
38349186799
-
Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors
-
Maeng S., Zarate C.A., Du J., Schloesser R.J., McCammon J., Chen G., Manji H.K. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol. Psychiatry 2008, 63:349-352.
-
(2008)
Biol. Psychiatry
, vol.63
, pp. 349-352
-
-
Maeng, S.1
Zarate, C.A.2
Du, J.3
Schloesser, R.J.4
McCammon, J.5
Chen, G.6
Manji, H.K.7
-
22
-
-
80052477010
-
Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo- and olanzapine-controlled study
-
Meltzer H.Y., Cucchiaro J., Silva R., Ogasa M., Phillips D., Xu J., Kalali A.H., Schweizer E., Pikalov A., Loebel A. Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo- and olanzapine-controlled study. Am. J. Psychiatry 2011, 168:957-967.
-
(2011)
Am. J. Psychiatry
, vol.168
, pp. 957-967
-
-
Meltzer, H.Y.1
Cucchiaro, J.2
Silva, R.3
Ogasa, M.4
Phillips, D.5
Xu, J.6
Kalali, A.H.7
Schweizer, E.8
Pikalov, A.9
Loebel, A.10
-
23
-
-
0026721811
-
Heteromeric NMDA receptors: molecular and functional distinction of subtypes
-
Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., Burnashev N., Sakmann B., Seeburg P.H. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 1992, 256:1217-1221.
-
(1992)
Science
, vol.256
, pp. 1217-1221
-
-
Monyer, H.1
Sprengel, R.2
Schoepfer, R.3
Herb, A.4
Higuchi, M.5
Lomeli, H.6
Burnashev, N.7
Sakmann, B.8
Seeburg, P.H.9
-
24
-
-
84877148445
-
Ketamine regulates the presynaptic release machinery in the hippocampus
-
Muller H.K., Wegener G., Liebenberg N., Zarate C.A., Popoli M., Elfving B. Ketamine regulates the presynaptic release machinery in the hippocampus. J. Psychiatr. Res. 2013, 47:892-899.
-
(2013)
J. Psychiatr. Res.
, vol.47
, pp. 892-899
-
-
Muller, H.K.1
Wegener, G.2
Liebenberg, N.3
Zarate, C.A.4
Popoli, M.5
Elfving, B.6
-
26
-
-
33846920665
-
NMDA receptor subunits: function and pharmacology
-
Paoletti P., Neyton J. NMDA receptor subunits: function and pharmacology. Curr. Opin. Pharmacol. 2007, 7:39-47.
-
(2007)
Curr. Opin. Pharmacol.
, vol.7
, pp. 39-47
-
-
Paoletti, P.1
Neyton, J.2
-
27
-
-
84901720404
-
Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction
-
Pehrson A.L., Sanchez C. Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction. CNS Spectr. 2014, 19:121-133.
-
(2014)
CNS Spectr.
, vol.19
, pp. 121-133
-
-
Pehrson, A.L.1
Sanchez, C.2
-
28
-
-
34547236227
-
Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus
-
Pittaluga A., Raiteri L., Longordo F., Luccini E., Barbiero V.S., Racagni G., Popoli M., Raiteri M. Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus. Neuropharmacology 2007, 53:27-36.
-
(2007)
Neuropharmacology
, vol.53
, pp. 27-36
-
-
Pittaluga, A.1
Raiteri, L.2
Longordo, F.3
Luccini, E.4
Barbiero, V.S.5
Racagni, G.6
Popoli, M.7
Raiteri, M.8
-
29
-
-
70349145407
-
Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study
-
Price J., Cole V., Goodwin G.M. Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study. Br. J. Psychiatry: J. Ment. Sci. 2009, 195:211-217.
-
(2009)
Br. J. Psychiatry: J. Ment. Sci.
, vol.195
, pp. 211-217
-
-
Price, J.1
Cole, V.2
Goodwin, G.M.3
-
30
-
-
3042696715
-
Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression
-
Sanacora G., Gueorguieva R., Epperson C.N., Wu Y.T., Appel M., Rothman D.L., Krystal J.H., Mason G.F. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch. Gen. Psychiatry 2004, 61:705-713.
-
(2004)
Arch. Gen. Psychiatry
, vol.61
, pp. 705-713
-
-
Sanacora, G.1
Gueorguieva, R.2
Epperson, C.N.3
Wu, Y.T.4
Appel, M.5
Rothman, D.L.6
Krystal, J.H.7
Mason, G.F.8
-
31
-
-
80054116238
-
Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders
-
Sanacora G., Treccani G., Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 2012, 62:63-77.
-
(2012)
Neuropharmacology
, vol.62
, pp. 63-77
-
-
Sanacora, G.1
Treccani, G.2
Popoli, M.3
-
32
-
-
42949123365
-
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
-
Sanacora G., Zarate C.A., Krystal J.H., Manji H.K. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat. Rev. Drug Discov. 2008, 7:426-437.
-
(2008)
Nat. Rev. Drug Discov.
, vol.7
, pp. 426-437
-
-
Sanacora, G.1
Zarate, C.A.2
Krystal, J.H.3
Manji, H.K.4
-
33
-
-
0030032399
-
Adaptation of N-methyl-d-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression
-
Skolnick P., Layer R.T., Popik P., Nowak G., Paul I.A., Trullas R. Adaptation of N-methyl-d-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. Pharmacopsychiatry 1996, 29:23-26.
-
(1996)
Pharmacopsychiatry
, vol.29
, pp. 23-26
-
-
Skolnick, P.1
Layer, R.T.2
Popik, P.3
Nowak, G.4
Paul, I.A.5
Trullas, R.6
-
34
-
-
84901910426
-
NMDA receptor antagonists ketamine and Ro25-6981 inhibit evoked release of glutamate in vivo in the subiculum
-
Stan T.L., Alvarsson A., Branzell N., Sousa V.C., Svenningsson P. NMDA receptor antagonists ketamine and Ro25-6981 inhibit evoked release of glutamate in vivo in the subiculum. Transl. Psychiatry 2014, 4:e395.
-
(2014)
Transl. Psychiatry
, vol.4
, pp. e395
-
-
Stan, T.L.1
Alvarsson, A.2
Branzell, N.3
Sousa, V.C.4
Svenningsson, P.5
-
35
-
-
0034652091
-
Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors
-
Svenningsson P., Lindskog M., Ledent C., Parmentier M., Greengard P., Fredholm B.B., Fisone G. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc. Natl. Acad. Sci. USA 2000, 97:1856-1860.
-
(2000)
Proc. Natl. Acad. Sci. USA
, vol.97
, pp. 1856-1860
-
-
Svenningsson, P.1
Lindskog, M.2
Ledent, C.3
Parmentier, M.4
Greengard, P.5
Fredholm, B.B.6
Fisone, G.7
-
36
-
-
0037022576
-
Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac)
-
Svenningsson P., Tzavara E.T., Witkin J.M., Fienberg A.A., Nomikos G.G., Greengard P. Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac). Proc. Natl. Acad. Sci. USA 2002, 99:3182-3187.
-
(2002)
Proc. Natl. Acad. Sci. USA
, vol.99
, pp. 3182-3187
-
-
Svenningsson, P.1
Tzavara, E.T.2
Witkin, J.M.3
Fienberg, A.A.4
Nomikos, G.G.5
Greengard, P.6
-
37
-
-
84862907507
-
The novel antipsychotic drug lurasidone enhances N-methyl-d-aspartate receptor-mediated synaptic responses
-
Yuen E.Y., Li X., Wei J., Horiguchi M., Meltzer H.Y., Yan Z. The novel antipsychotic drug lurasidone enhances N-methyl-d-aspartate receptor-mediated synaptic responses. Mol. Pharmacol. 2012, 81:113-119.
-
(2012)
Mol. Pharmacol.
, vol.81
, pp. 113-119
-
-
Yuen, E.Y.1
Li, X.2
Wei, J.3
Horiguchi, M.4
Meltzer, H.Y.5
Yan, Z.6
-
38
-
-
33746896935
-
A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression
-
Zarate C.A., Singh J.B., Carlson P.J., Brutsche N.E., Ameli R., Luckenbaugh D.A., Charney D.S., Manji H.K. A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry 2006, 63:856-864.
-
(2006)
Arch. Gen. Psychiatry
, vol.63
, pp. 856-864
-
-
Zarate, C.A.1
Singh, J.B.2
Carlson, P.J.3
Brutsche, N.E.4
Ameli, R.5
Luckenbaugh, D.A.6
Charney, D.S.7
Manji, H.K.8
-
39
-
-
84874931844
-
Supertertiary structure of the MAGUK core from PSD-95
-
Zhang J., Lewis S.M., Kuhlman B., Lee A.L. Supertertiary structure of the MAGUK core from PSD-95. Structure 2013, 21:402-413.
-
(2013)
Structure
, vol.21
, pp. 402-413
-
-
Zhang, J.1
Lewis, S.M.2
Kuhlman, B.3
Lee, A.L.4
|